Z17.421 - Hormone receptor negative with human epidermal growth factor receptor 2 negative status
- Applicable to Hormone receptor negative with human epidermal growth factor receptor 2 negative status
- The 2025 edition of ICD10-CM Z17.421 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z17.421 - other international versions of ICD10 Z17.421 may differ.
- Z17.421 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion Term
- HR- with HER2-
- TNBC
- Triple negative breast cancer
The following codes above Z17.421 contain annotation back-references that may be applicable to Z17.421:
Chapter: Z00-Z99 Factors influencing health status and contact with health services
Section: Z17 Estrogen, and other hormones and factors receptor status
Category: Z17 Estrogen receptor status
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com